American Shared Hospital Services Shares Outstanding 2006-2018 | AMS
American Shared Hospital Services shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| American Shared Hospital Services Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2017 | 6 |
| 2016 | 6 |
| 2015 | 6 |
| 2014 | 5 |
| 2013 | 5 |
| 2012 | 5 |
| 2011 | 5 |
| 2010 | 5 |
| 2009 | 5 |
| 2008 | 5 |
| 2007 | 5 |
| 2006 | 5 |
| 2005 | 5 |
| American Shared Hospital Services Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q3 2018 | 6 |
| Q2 2018 | 6 |
| Q1 2018 | 6 |
| Q4 2017 | 6 |
| Q3 2017 | 6 |
| Q2 2017 | 6 |
| Q1 2017 | 6 |
| Q4 2016 | 6 |
| Q3 2016 | 6 |
| Q2 2016 | 6 |
| Q1 2016 | 6 |
| Q4 2015 | 6 |
| Q3 2015 | 6 |
| Q2 2015 | 5 |
| Q1 2015 | 6 |
| Q4 2014 | 5 |
| Q3 2014 | 5 |
| Q2 2014 | 5 |
| Q1 2014 | 5 |
| Q4 2013 | 5 |
| Q3 2013 | 5 |
| Q2 2013 | 5 |
| Q1 2013 | 5 |
| Q4 2012 | 5 |
| Q3 2012 | 5 |
| Q2 2012 | 5 |
| Q1 2012 | 5 |
| Q4 2011 | 5 |
| Q3 2011 | 5 |
| Q2 2011 | 5 |
| Q1 2011 | 5 |
| Q4 2010 | 5 |
| Q3 2010 | 5 |
| Q2 2010 | 5 |
| Q1 2010 | 5 |
| Q4 2009 | 5 |
| Q3 2009 | 5 |
| Q2 2009 | 5 |
| Q1 2009 | 5 |
| Q4 2008 | 5 |
| Q3 2008 | 5 |
| Q2 2008 | 5 |
| Q1 2008 | 5 |
| Q4 2007 | 5 |
| Q3 2007 | 5 |
| Q2 2007 | 5 |
| Q1 2007 | 5 |
| Q4 2006 | 5 |
| Q3 2006 | 5 |
| Q2 2006 | 5 |
| Q1 2006 | 5 |
| Q4 2005 | 5 |
| Q3 2005 | 5 |
| Q2 2005 | 5 |
| Q1 2005 | 5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.016B | $0.020B |
| American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery services, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia . The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the twenty first Century concept. Through its equity investment in Still River Systems, AMS also plans to complement these services with the Clinatron-two hundred fifty, proton beam radiation therapy system, which has not yet been approved by the FDA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $105.261B | 23.72 |
| Intuitive Surgical (ISRG) | United States | $64.748B | 60.48 |
| Edwards Lifesciences (EW) | United States | $39.266B | 40.21 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.664B | 16.20 |
| IDEXX Laboratories (IDXX) | United States | $18.873B | 51.39 |
| ABIOMED (ABMD) | United States | $14.572B | 96.19 |
| Teleflex (TFX) | United States | $13.884B | 30.44 |
| Hologic (HOLX) | United States | $13.648B | 20.64 |
| Varian Medical Systems (VAR) | United States | $12.581B | 31.43 |
| DexCom (DXCM) | United States | $11.613B | 444.93 |
| STERIS (STE) | United Kingdom | $10.406B | 26.74 |
| Masimo (MASI) | United States | $7.109B | 44.26 |
| Penumbra (PEN) | United States | $5.474B | 309.73 |
| Integra LifeSciences Holdings (IART) | United States | $4.712B | 22.85 |
| Globus Medical (GMED) | United States | $4.682B | 28.42 |
| LivaNova (LIVN) | United Kingdom | $4.628B | 28.53 |
| Wright Medical Group (WMGI) | Netherlands | $3.980B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.969B | 0.00 |
| Glaukos (GKOS) | United States | $2.896B | 0.00 |
| Cantel Medical (CMD) | United States | $2.757B | 27.41 |
| Integer Holdings (ITGR) | United States | $2.736B | 22.32 |
| Inogen (INGN) | United States | $1.966B | 39.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.941B | 21.08 |
| Nevro (NVRO) | United States | $1.885B | 0.00 |
| OPKO Health (OPK) | United States | $1.557B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.083B | 0.00 |
| Luminex (LMNX) | United States | $1.067B | 48.73 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.059B | 28.78 |
| Tactile Systems Technology (TCMD) | United States | $1.045B | 198.46 |
| CryoLife (CRY) | United States | $1.043B | 112.44 |
| Veracyte (VCYT) | United States | $1.006B | 0.00 |
| Intersect ENT (XENT) | United States | $0.968B | 0.00 |
| Fluidigm (FLDM) | United States | $0.938B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.875B | 35.79 |
| Natus Medical (BABY) | United States | $0.851B | 17.75 |
| AngioDynamics (ANGO) | United States | $0.811B | 26.30 |
| ViewRay (VRAY) | United States | $0.808B | 0.00 |
| AxoGen (AXGN) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.654B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.556B | 0.00 |
| TransEnterix (TRXC) | United States | $0.482B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.462B | 48.72 |
| Si-Bone (SIBN) | United States | $0.440B | 0.00 |
| Accuray (ARAY) | United States | $0.414B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.412B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.390B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.372B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.357B | 52.09 |
| IRadimed (IRMD) | United States | $0.304B | 64.19 |
| SeaSpine Holdings (SPNE) | United States | $0.282B | 0.00 |
| Sientra (SIEN) | United States | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.262B | 0.00 |
| Nuvectra (NVTR) | United States | $0.206B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.188B | 43.67 |
| ConforMIS (CFMS) | United States | $0.162B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.159B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.153B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.129B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.121B | 0.00 |
| SOLITON INC (SOLY) | $0.114B | 0.00 | |
| Alphatec Holdings (ATEC) | United States | $0.114B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.106B | 0.00 |
| Vermillion (VRML) | United States | $0.103B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.088B | 0.00 |
| EDAP TMS (EDAP) | France | $0.085B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.073B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.065B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.045B | 23.17 |
| Viveve Medical (VIVE) | United States | $0.044B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.040B | 0.00 |
| Avinger (AVGR) | United States | $0.037B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.037B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.028B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.021B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.021B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.021B | 66.67 |
| Dynatronics (DYNT) | United States | $0.017B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.012B | 0.00 |
| Neovasc (NVCN) | Canada | $0.012B | 0.00 |
| Micron Solutions (MICR) | United States | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
